There is a risk of the devices sending a reduced amount of energy to the heart during defibrillation. More than 7,000 devices are being recalled due to this issue.

There have been 30 complaints so far about this issue, including 26 injuries and four deaths.

The FDA has categorized this as a Class I recall, which means using the devices “may cause serious injuries or death.”

Rep. Mike Carey introduced the Imaging Services Price Transparency Act July 25, hoping to better inform patients about services provided by the specialty. 

Plaintiff attorneys are asking for damages in excess of $5 million, not including interest and other costs, and seeking class-action status.

The physician had assigned the standard, four-phase protocol for liver imaging, but the radiographer instead performed a single, portal-venous phase only.

Also, MITA urges states to fix breast screening coverage gap, Philips announces Q2 earnings results, and Aidoc inks partnerships with two large health systems. 

The updated recommendations from the American College of Cardiology and American Heart Association cover a variety of topics, including patient communication, follow-up imaging, nutritional supplements and more.